Clinical Trial Update: Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating the effects and safety of sacubitril/valsartan in patients with resistant hypertension; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Resistant Hypertension | Phase 3 | Status: UNKNOWN